Dapagliflozin effect on heart failure with prevalent or new-onset atrial fibrillation

Vicente Artola Arita; Dirk J Van Veldhuisen; Michiel Rienstra

doi:10.1002/ejhf.2443

Dapagliflozin effect on heart failure with prevalent or new-onset atrial fibrillation

Vicente Artola Arita, Dirk J Van Veldhuisen, Michiel Rienstra

Cardiovascular Centre (CVC)

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

30 Downloads (Pure)

Original language	English
Pages (from-to)	526-528
Number of pages	3
Journal	European Journal of Heart Failure
Volume	24
Issue number	3
DOIs	https://doi.org/10.1002/ejhf.2443
Publication status	Published - 2022

Keywords

Atrial Fibrillation/drug therapy
Benzhydryl Compounds/therapeutic use
Glucosides/therapeutic use
Heart Failure/drug therapy
Humans

Access to Document

10.1002/ejhf.2443Licence: CC BY-NC

Validating risk models versus age alone for atrial fibrillation in a young Dutch population cohort should atrial fibrillation risk prediction be expanded to younger community membersFinal publisher's version, 1.19 MBLicence: CC BY-NC

Handle.net

Persistent link

Cite this

@article{92d72cff89c74ffe989cc1ac6a8ca8a3,

title = "Dapagliflozin effect on heart failure with prevalent or new-onset atrial fibrillation",

keywords = "Atrial Fibrillation/drug therapy, Benzhydryl Compounds/therapeutic use, Glucosides/therapeutic use, Heart Failure/drug therapy, Humans",

author = "{Artola Arita}, Vicente and {Van Veldhuisen}, {Dirk J} and Michiel Rienstra",

year = "2022",

doi = "10.1002/ejhf.2443",

language = "English",

volume = "24",

pages = "526--528",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley",

number = "3",

}

TY - JOUR

T1 - Dapagliflozin effect on heart failure with prevalent or new-onset atrial fibrillation

AU - Artola Arita, Vicente

AU - Van Veldhuisen, Dirk J

AU - Rienstra, Michiel

PY - 2022

Y1 - 2022

KW - Atrial Fibrillation/drug therapy

KW - Benzhydryl Compounds/therapeutic use

KW - Glucosides/therapeutic use

KW - Heart Failure/drug therapy

KW - Humans

U2 - 10.1002/ejhf.2443

DO - 10.1002/ejhf.2443

M3 - Article

C2 - 35118766

SN - 1388-9842

VL - 24

SP - 526

EP - 528

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 3

ER -